Hologic Inc. Files 2025 Proxy Statement

Ticker: HOLX · Form: DEF 14A · Filed: Jan 16, 2025 · CIK: 859737

Hologic INC DEF 14A Filing Summary
FieldDetail
CompanyHologic INC (HOLX)
Form TypeDEF 14A
Filed DateJan 16, 2025
Risk Levellow
Pages15
Reading Time18 min
Key Dollar Amounts$1.3 billion, $2.4 billion, $955 million, $1.16 billion, $800 m
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, annual-meeting, shareholder-voting

TL;DR

Hologic's 2025 proxy statement is out - shareholders vote soon.

AI Summary

Hologic Inc. filed its DEF 14A proxy statement on January 16, 2025, for its fiscal year ending September 28, 2025. The filing provides details regarding the company's annual meeting and matters to be voted on by shareholders. Hologic, Inc. is headquartered in Marlborough, MA, and operates in the X-Ray Apparatus & Tubes & Related Irradiation Apparatus industry.

Why It Matters

This filing is crucial for shareholders as it outlines the agenda for the annual meeting, including any proposals or director elections, allowing them to make informed voting decisions.

Risk Assessment

Risk Level: low — This is a routine annual filing (DEF 14A) that provides information to shareholders and does not typically contain new material risks.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of a DEF 14A filing?

A DEF 14A filing, also known as a Proxy Statement, is used by companies to solicit proxy votes from shareholders for their annual or special meetings.

When is Hologic Inc.'s fiscal year end?

Hologic Inc.'s fiscal year ends on September 28 (0928).

What is Hologic Inc.'s primary business classification?

Hologic Inc. is classified under 'X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS' with SIC code 3844.

On what date was this DEF 14A filing submitted?

This DEF 14A filing was submitted on January 16, 2025.

Where is Hologic Inc. headquartered?

Hologic Inc. is headquartered at 250 Campus Drive, Marlborough, MA 01752.

Filing Stats: 4,399 words · 18 min read · ~15 pages · Grade level 14.6 · Accepted 2025-01-16 16:16:23

Key Financial Figures

Filing Documents

Executive Compensation Best Practices

Executive Compensation Best Practices 55 Compensation of Executive Officers 56 Our Compensation Philosophy 56 Principal Elements of Pay: Total Direct Compensation 56 Fiscal 2024 Total Direct Compensation Elements in Detail 57 Other Compensation 71 Our Decision-Making Process 72 Additional Compensation Practices, Policies & Guidelines 74

Executive Compensation Tables

Executive Compensation Tables 77 Summary Compensation Table 77 Grants of Plan-Based Awards 79 Outstanding Equity Awards at Fiscal Year End 81 Option Exercises and Stock Vested 84 Non-Qualified Deferred Compensation 85 Potential Payments upon Termination or Change of Control 86 Change of Control and Severance Agreements 87 Equity Agreements 89 Pay Ratio 89 Pay Versus Performance 90 Proposal No. 3 – Ratification of Independent Registered Public Accounting Firm 95 Independent Registered Public Accounting Firm Fees 96 Audit and Finance Committee Policy on Pre-Approval of Services 96 Audit and Finance Committee Report 97 Proposal No. 4 – Stockholder Proposal: Simple Majority Vote 98 Stock Ownership 100 Securities Ownership by Directors and Executive Officers 100

Security Ownership by Certain Beneficial Owners

Security Ownership by Certain Beneficial Owners 102 General Information about the Meeting and Voting 103 Stockholder Proposals for the 2026 Annual Meeting 107 Incorporation by Reference 108 Financial Matters and Form 10-K 109 Annex A Non-GAAP Reconciliation A-1 TABLE OF CONTENTS Proxy Statement Summary This summary highlights information contained elsewhere in this proxy statement. This summary does not contain all of the information that you should consider, and you should read the entire proxy statement and the Company's most recent Annual Report on Form 10-K before casting your vote. References to "Hologic," the "Company," "we," "us" or "our" refer to Hologic, Inc. and its subsidiaries. 2025 Annual Meeting of Stockholders MEETING AGENDA AND VOTING RECOMMENDATIONS Proposal Board Recommendation Page Election of Eight Directors FOR each nominee 20 Say-on-Pay: Advisory Vote to Approve Executive Compensation FOR 41 Ratification of the Appointment of Ernst & Young LLP for fiscal 2025 FOR 95 Stockholder Proposal: Simple Majority Vote NO VOTING RECOMMENDATION 98 Attendance: All stockholders who were stockholders of record and beneficial owners as of January 6, 2025 may attend the Annual Meeting. Stockholders who plan to attend the meeting must present a valid government-issued picture identification such as a driver's license or passport. Stockholders of record will be verified against an official list available at the registration area. If your shares are held in the name of a bank, broker or other holder of record (an intermediary), please also bring your bank or brokerage statement evidencing your beneficial ownership of Hologic stock to gain admission. As the beneficial owner, you have the right to direct your intermediary on how to vote and are also invited to attend the meeting; however, since you are not the stockholder of record, you may not vote these shares in person at the meeting, unless you obtain a

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing